The European Medicines Agency rejects the authorization of aducanumab for Alzheimer's disease

被引：0
|
作者：
Dal-Re, Rafael [1 ]
机构：
[1] Univ Autonoma Madrid, Hosp Univ Fdn Jimenez Diaz, Inst Invest Sanitaria, Unidad Epidemiol, Madrid, Spain
来源：
REVISTA DE NEUROLOGIA | 2022年 / 74卷 / 06期
关键词：
APPROVAL;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：207 / 208
页数：2
相关论文
共 50 条
  • [1] Aducanumab: European agency rejects Alzheimer's drug over efficacy and safety concerns
    Mahase, Elisabeth
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 375 : n3127
  • [2] The European Medicines Agency's strategies to meet the challenges of Alzheimer disease
    Haas, Manuel
    Mantua, Valentina
    Haberkamp, Marion
    Pani, Luca
    Isaac, Maria
    Butlen-Ducuing, Florence
    Vamvakas, Spiros
    Broich, Karl
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (04) : 221 - 222
  • [3] The European Medicines Agency's strategies to meet the challenges of Alzheimer disease
    Manuel Haas
    Valentina Mantua
    Marion Haberkamp
    Luca Pani
    Maria Isaac
    Florence Butlen-Ducuing
    Spiros Vamvakas
    Karl Broich
    [J]. Nature Reviews Drug Discovery, 2015, 14 : 221 - 222
  • [4] Aducanumab for Alzheimer's disease?
    Walsh, Sebastian
    Merrick, Richard
    Milne, Richard
    Brayne, Carol
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
  • [5] European Medicines Agency grants full marketing authorization for pazopanib
    Chamberlain, Dominic
    [J]. FUTURE ONCOLOGY, 2013, 9 (09) : 1264 - 1264
  • [6] ADUCANUMAB FOR ALZHEIMER'S DISEASE? Aducanumab, amyloid, and culture wars
    Iliffe, Steve
    Manthorpe, Jill
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
  • [7] Aducanumab for the Treatment of Alzheimer's Disease
    Sarbacker, G. Blair
    [J]. US PHARMACIST, 2021, 46 (10) : 51 - 57
  • [8] Targeting Alzheimer's Disease With Aducanumab
    不详
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (06) : 580 - 580
  • [9] A resurrection of aducanumab for Alzheimer's disease
    Schneider, Lon
    [J]. LANCET NEUROLOGY, 2020, 19 (02): : 111 - 112
  • [10] Aducanumab (Aduhelm) for Alzheimer's Disease
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1628): : 105 - 106
12345